List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 25 studies with search of: "Tazobactam"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Standard Vs Adjusted Dosing of Piperacillin/Tazobactam in Acute Renal Failure and Septic Shock
Conditions: Septic Shock;   Acute Renal Failure
Interventions: Drug: Piperacillin/Tazobactam;   Drug: Piperacillin/Tazobactam
2 Recruiting Moxifloxacin Plus Metronidazole Versus Piperacillin/Tazobactam for the Treatment of Patients With Intra-Abdominal Abscesses
Condition: Abscess, Intra-Abdominal
Intervention: Drug: Moxifloxacin/Metronidazole or Piperacillin/Tazobactam
3 Recruiting Pharmacokinetics of Piperacillin/Tazobactam in Patients Treated by Continuous Renal Replacement Therapy
Conditions: Diffusive and Convective Clearance;   Body Clearance;   Piperacillin Tazocilline Concentrations (Cmin)
Intervention: Drug: piperacillin/tazobactam
4 Recruiting Study Comparing Piperacillin-Tazobactam Versus Piperacillin-Tazobactam Plus Glycopeptide in Neutropenic Patients
Conditions: Hematological Malignancy;   Leukemia;   Myelodysplasia;   Lymphoma;   Myeloma;   Stem Cell Transplantation
Interventions: Drug: piperacillin-tazobactam;   Drug: glycopeptide
5 Active, not recruiting Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count
Conditions: Cancer-Related Problem/Condition;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Unspecified Adult Solid Tumor, Protocol Specific;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: piperacillin sodium;   Drug: piperacillin-tazobactam;   Drug: tazobactam sodium;   Drug: vancomycin
6 Completed Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection
Conditions: Abscess;   Wound Infection;   Diabetic Foot;   Ulcer;   Infection
Interventions: Drug: Moxifloxacin intravenous and per os;   Drug: Piperacillin/Tazobactam intravenous, Amoxicillin/Clavulanic acid per os
7 Not yet recruiting Pharmacokinetics and Safety of Piperacillin-Tazobactam in Neonates
Condition: Sepsis
Intervention: Drug: piperacillin-tazobactam
8 Recruiting Study Evaluating Piperacillin/Tazobactam in Complicated Urinary Infections.
Condition: Urinary Infections
Intervention: Drug: piperacillin/tazobactam
9 Completed Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units
Conditions: Gram-Positive Bacterial Infections;   Escherichia Coli Infections;   Klebsiella Infections
Intervention: Drug: piperacillin-tazobactam
10 Completed Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot Infections
Conditions: Diabetes Mellitus;   Diabetic Foot
Intervention: Drug: Piperacillin/Tazobactam
11 Completed Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma
Condition: Hematologic Neoplasms
Intervention: Drug: Piperacillin/Tazobactam (Tazocin)
12 Completed Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections
Condition: Complicated Intra-Abdominal Infections
Interventions: Drug: MK0826, /Duration of Treatment : 8 Weeks;   Drug: Comparator : piperacillin sodium (+) tazobactam sodium /Duration of Treatment : 8 Weeks
13 Completed Study to Demonstrate the Clinical Efficacy of Levofloxacin in the Treatment of Pneumonia
Condition: Pneumonia
Interventions: Drug: Levofloxacin;   Drug: Piperacillin/Tazobactam
14 Recruiting Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase
Conditions: Bacteremia;   AmpC Beta-Lactamase
Intervention:
15 Completed Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults
Condition: Foot Infections in Diabetic Patients
Interventions: Drug: MK0826, ertapenem sodium / Duration of Treatment - 24 weeks;   Drug: Comparator: Piperacillin/Tazobactam / Duration of Treatment - 24 weeks
16 Terminated Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous Infusion
Conditions: Pneumonia;   Bacteremia
Interventions: Drug: Meropenem;   Drug: Vancomycin;   Drug: Linezolid;   Drug: Piperacillin/Tazobactam;   Drug: Cefepim;   Drug: Ceftazidim
17 Recruiting Antimicrobial PK in Infants With Suspected or Confirmed Infection
Condition: Infection
Interventions: Drug: Ampicillin;   Drug: Metronidazole;   Drug: Piperacillin/Tazobactam;   Drug: Acyclovir;   Drug: Amphotericin B;   Drug: Ambisome;   Drug: Anidulafungin;   Drug: Caspofungin
18 Completed Study Evaluating Zosyn in Hospitalized Patients With Intra-Abdominal Infection
Condition: Bacterial Infections
Intervention: Drug: Piperacillin/Tazobactam
19 Completed Pilot Study of the Utility of Empiric Antibiotic Therapy for Suspected ICU-Acquired Infection
Conditions: Nosocomial Infection;   Pneumonia;   Systemic Inflammatory Response Syndrome;   Critical Illness;   Pyrexia
Interventions: Drug: Site-specific empiric regimens included: Meropenem;   Drug: Piperacillin/tazobactam;   Drug: Ciprofloxacin and cefazolin +/- metronidazole
20 Completed Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)
Conditions: Cystic Fibrosis;   Chronic Bronchitis
Interventions: Drug: IV amikacin;   Drug: PO azithromycin;   Drug: IV ceftazidime;   Drug: PO ciprofloxacin;   Drug: IV meropenem;   Drug: IV piperacillin-tazobactam;   Drug: IV ticarcillin-clavulanate;   Drug: IV tobramycin

Previous Page Studies Shown (1-20) Next Page (21-25)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services